Literature DB >> 26494585

Increasing incidence of infantile hemangiomas (IH) over the past 35 years: Correlation with decreasing gestational age at birth and birth weight.

Katelyn R Anderson1, Jennifer J Schoch1, Christine M Lohse2, Jennifer L Hand3, Dawn M Davis4, Megha M Tollefson5.   

Abstract

BACKGROUND: Infantile hemangiomas (IH) are the most common soft-tissue tumors of infancy, but little is known regarding their true incidence.
OBJECTIVES: We sought to determine the current incidence of IH and examine trends in incidence, demographics, and lesion characteristics over 3 decades.
METHODS: The Rochester Epidemiology Project was used to identify infants residing in Olmsted County, Minnesota, who were given a diagnosis of IH between January 1, 1976, and December 31, 2010.
RESULTS: In all, 999 infants were given a diagnosis of IH. Incidence increased over the 3-decade study period from 0.97 to 1.97 per 100 person-years (P < .001). Average gestational age at birth and birth weight for infants with IH decreased over the study period (39.2-38.3 weeks, P < .001 and 3383-3185 g, P = .003, respectively). The overall age- and sex-adjusted incidence of IH was 1.64 per 100 person-years (95% confidence interval 1.54-1.75). LIMITATIONS: The population of Olmsted County, Minnesota, is predominantly non-Hispanic white, limiting our ability to report racial differences in incidence. This was a retrospective study.
CONCLUSIONS: This study provides a longitudinal, population-based incidence of IH. Incidence has increased steadily over the past 3 decades, correlating significantly with decreasing gestational age at birth and birth weight in affected infants.
Copyright © 2015 American Academy of Dermatology, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  hemangioma; incidence; infantile hemangioma; vascular anomaly; vascular birthmark; vascular tumor

Mesh:

Year:  2015        PMID: 26494585      PMCID: PMC4994883          DOI: 10.1016/j.jaad.2015.08.024

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  26 in total

1.  The prevalence and risk factors of infantile haemangiomas: a case-control study in the Dutch population.

Authors:  Marije J Hoornweg; Mark J C Smeulders; Dirk T Ubbink; Chantal M A M van der Horst
Journal:  Paediatr Perinat Epidemiol       Date:  2011-09-20       Impact factor: 3.980

2.  Infantile hemangiomas: current knowledge, future directions. Proceedings of a research workshop on infantile hemangiomas, April 7-9, 2005, Bethesda, Maryland, USA.

Authors:  Ilona J Frieden; Anita N Haggstrom; Beth A Drolet; Anthony J Mancini; Sheila Fallon Friedlander; Laurence Boon; Sarah L Chamlin; Eulalia Baselga; Maria C Garzon; Amy J Nopper; Dawn H Siegel; Erin W Mathes; Deborah S Goddard; Joyce Bischoff; Paula E North; Nancy B Esterly
Journal:  Pediatr Dermatol       Date:  2005 Sep-Oct       Impact factor: 1.588

3.  Propranolol for severe hemangiomas of infancy.

Authors:  Christine Léauté-Labrèze; Eric Dumas de la Roque; Thomas Hubiche; Franck Boralevi; Jean-Benoît Thambo; Alain Taïeb
Journal:  N Engl J Med       Date:  2008-06-12       Impact factor: 91.245

4.  The incidence of birthmarks in the neonate.

Authors:  A H Jacobs; R G Walton
Journal:  Pediatrics       Date:  1976-08       Impact factor: 7.124

5.  Strawberry hemangioma in preterm infants.

Authors:  J Amir; A Metzker; R Krikler; S H Reisner
Journal:  Pediatr Dermatol       Date:  1986-09       Impact factor: 1.588

6.  Prospective study of infantile hemangiomas: demographic, prenatal, and perinatal characteristics.

Authors:  Anita N Haggstrom; Beth A Drolet; Eulalia Baselga; Sarah L Chamlin; Maria C Garzon; Kimberly A Horii; Anne W Lucky; Anthony J Mancini; Denise W Metry; Brandon Newell; Amy J Nopper; Ilona J Frieden
Journal:  J Pediatr       Date:  2007-03       Impact factor: 4.406

7.  A randomized controlled trial of propranolol for infantile hemangiomas.

Authors:  Marcia Hogeling; Susan Adams; Orli Wargon
Journal:  Pediatrics       Date:  2011-07-25       Impact factor: 7.124

8.  Use of a medical records linkage system to enumerate a dynamic population over time: the Rochester epidemiology project.

Authors:  Jennifer L St Sauver; Brandon R Grossardt; Barbara P Yawn; L Joseph Melton; Walter A Rocca
Journal:  Am J Epidemiol       Date:  2011-03-23       Impact factor: 4.897

9.  Congenital vascular lesions: clinical application of a new classification.

Authors:  M C Finn; J Glowacki; J B Mulliken
Journal:  J Pediatr Surg       Date:  1983-12       Impact factor: 2.545

10.  Prospective study of infantile haemangiomas: incidence, clinical characteristics and association with placental anomalies.

Authors:  A Munden; R Butschek; W L Tom; J S Marshall; D M Poeltler; S E Krohne; A B Alió; M Ritter; D F Friedlander; V Catanzarite; A Mendoza; L Smith; M Friedlander; S F Friedlander
Journal:  Br J Dermatol       Date:  2014-04       Impact factor: 9.302

View more
  12 in total

Review 1.  Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.

Authors:  Chelsey J Forbess Smith; Sheila Fallon Friedlander; Monica Guma; Arthur Kavanaugh; Christina D Chambers
Journal:  Birth Defects Res       Date:  2017-04-12       Impact factor: 2.344

2.  Beta Blockers in the Treatment of Periocular Infantile Hemangiomas: A Review.

Authors:  Ann Q Tran; Catherine J Choi; Sara T Wester
Journal:  Intern Med Rev (Wash D C)       Date:  2016-10

3.  Sirolimus for diffuse intestinal infantile hemangioma with PHACE features: systematic review.

Authors:  Elana P Kleinman; Francine Blei; Denise Adams; Shoshana Greenberger
Journal:  Pediatr Res       Date:  2022-09-30       Impact factor: 3.953

4.  Maternal and Perinatal Risk Factors for Infantile Hemangioma: A Matched Case-Control Study with a Large Sample Size.

Authors:  Xue Gong; Tong Qiu; Liwei Feng; Kaiying Yang; Shiyi Dai; Jiangyuan Zhou; Xuepeng Zhang; Siyuan Chen; Yi Ji
Journal:  Dermatol Ther (Heidelb)       Date:  2022-06-25

Review 5.  Incidence of diseases primarily affecting the skin by age group: population-based epidemiologic study in Olmsted County, Minnesota, and comparison with age-specific incidence rates worldwide.

Authors:  Laurel L Wessman; Louise K Andersen; Mark D P Davis
Journal:  Int J Dermatol       Date:  2018-01-29       Impact factor: 2.736

6.  Temporal trends in prenatal risk factors for the development of infantile hemangiomas.

Authors:  Jennifer J Schoch; Manrup K Hunjan; Katelyn R Anderson; Christine M Lohse; Jennifer L Hand; Dawn M R Davis; Megha M Tollefson
Journal:  Pediatr Dermatol       Date:  2018-09-06       Impact factor: 1.588

7.  Circular RNA profile of infantile hemangioma by microarray analysis.

Authors:  Cong Fu; Renrong Lv; Guangqi Xu; Linfeng Zhang; Jianhai Bi; Li Lin; Xiaowen Liu; Ran Huo
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

8.  Infantile hemangiomas: risk factors for complications, recurrence and unaesthetic sequelae.

Authors:  Letícia Gaertner Mariani; Lílian Moraes Ferreira; Diego Luiz Rovaris; Renan Rangel Bonamigo; Ana Elisa Kiszewski
Journal:  An Bras Dermatol       Date:  2021-11-27       Impact factor: 1.896

9.  The Use of Off-Label Medications in Newborn Infants Despite an Approved Alternative Being Available-Results of a National Survey.

Authors:  Alex Veldman; Eva Richter; Christian Hacker; Doris Fischer
Journal:  Pharmacy (Basel)       Date:  2022-01-25

10.  Infantile Hemangioma Presenting as Colocolic Intussusception in an Infant Case Report with Review of Pathologic Lead Points.

Authors:  Rehan Rais; Iván González; Jacqueline M Saito; Louis P Dehner
Journal:  Case Rep Pediatr       Date:  2018-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.